SEC registrant · CIK 0000794172

MERIDIAN BIOSCIENCE INC

MERIDIAN BIOSCIENCE INC (CIK 0000794172, EIN 31-0888197) reported revenue of $333.02 million ($333,018,000) for FY2022 (2021-10-01 to 2022-09-30) and net income of $42.46 million ($42,459,000) for FY2022 (2021-10-01 to 2022-09-30), as filed in its 10-K filed 2022-11-22 (accession 0001193125-22-290521).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends September 30).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0000794172
EIN31-0888197
SIC industry code2835 In Vitro & In Vivo Diagnostic Substances
State or country of incorporationOH
Fiscal year endSeptember 30
Filer categoryLarge accelerated filer
Entity typeoperating
Olympus entity IDorg_2h3n4nxqeg8yfwyfp51wzk722h
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$333,018,000FY20222021-10-01 to 2022-09-3010-K2022-11-220001193125-22-290521Revenues
Net income$42,459,000FY20222021-10-01 to 2022-09-3010-K2022-11-220001193125-22-290521NetIncomeLoss
Total assets$463,097,000FY2022as of 2022-09-3010-K2022-11-220001193125-22-290521Assets
Stockholders' equity$368,061,000FY2022as of 2022-09-3010-K2022-11-220001193125-22-290521StockholdersEquity
Operating cash flow$82,361,000FY20222021-10-01 to 2022-09-3010-K2022-11-220001193125-22-290521NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share$0.96 per shareFY20222021-10-01 to 2022-09-3010-K2022-11-220001193125-22-290521EarningsPerShareDiluted
Shares outstanding43,827,819 sharesFY2022as of 2022-10-3110-K2022-11-220001193125-22-290521EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2013-2022, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20222021-10-01 to 2022-09-30$333,018,00010-K2022-11-220001193125-22-290521
RevenueFY20212020-10-01 to 2021-09-30$317,896,00010-K2022-11-220001193125-22-290521
RevenueFY20202019-10-01 to 2020-09-30$253,667,00010-K2022-11-220001193125-22-290521
RevenueFY20192018-10-01 to 2019-09-30$201,014,00010-K2021-11-230001193125-21-337663
RevenueFY20182017-10-01 to 2018-09-30$213,571,00010-K2020-11-230001193125-20-300813
RevenueFY20172016-10-01 to 2017-09-30$200,771,00010-K2019-11-260001193125-19-300565
RevenueFY20162015-10-01 to 2016-09-30$196,082,00010-K2018-11-290001193125-18-337257
RevenueFY20152014-10-01 to 2015-09-30$194,830,00010-K2017-11-290001193125-17-354808
RevenueFY20142013-10-01 to 2014-09-30$188,832,00010-K2016-11-290001193125-16-779250
RevenueFY20132012-10-01 to 2013-09-30$188,686,00010-K2015-11-300001193125-15-390041
Net incomeFY20222021-10-01 to 2022-09-30$42,459,00010-K2022-11-220001193125-22-290521
Net incomeFY20212020-10-01 to 2021-09-30$71,407,00010-K2022-11-220001193125-22-290521
Net incomeFY20202019-10-01 to 2020-09-30$46,186,00010-K2022-11-220001193125-22-290521
Net incomeFY20192018-10-01 to 2019-09-30$24,382,00010-K2021-11-230001193125-21-337663
Net incomeFY20182017-10-01 to 2018-09-30$23,849,00010-K2020-11-230001193125-20-300813
Net incomeFY20172016-10-01 to 2017-09-30$21,557,00010-K2019-11-260001193125-19-300565
Net incomeFY20162015-10-01 to 2016-09-30$32,229,00010-K2018-11-290001193125-18-337257
Net incomeFY20152014-10-01 to 2015-09-30$35,540,00010-K2017-11-290001193125-17-354808
Net incomeFY20142013-10-01 to 2014-09-30$34,743,00010-K2016-11-290001193125-16-779250
Net incomeFY20132012-10-01 to 2013-09-30$38,032,00010-K2015-11-300001193125-15-390041

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2023-02-092022-12-310001193125-23-029272d436284d10q.htm
10-K/A2023-01-272022-09-300001193125-23-017550d447014d10ka.htm
10-K2022-11-222022-09-300001193125-22-290521d384542d10k.htm
10-Q2022-08-052022-06-300001193125-22-213186d348445d10q.htm
10-Q2022-05-062022-03-310001193125-22-143065d345909d10q.htm
10-Q2022-02-042021-12-310001193125-22-027781d241652d10q.htm
10-K2021-11-232021-09-300001193125-21-337663d228317d10k.htm
10-Q2021-08-062021-06-300001193125-21-238736d193931d10q.htm
10-Q2021-05-072021-03-310001193125-21-154105d144291d10q.htm
10-Q2021-02-052020-12-310001193125-21-029901d787840d10q.htm
10-K2020-11-232020-09-300001193125-20-300813d24550d10k.htm
10-Q2020-08-072020-06-300001193125-20-212537d16842d10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0000794172published by the sourcedata.sec.gov/submissions/CIK0000794172.json2026-10-21
Employer Identification Number (EIN) · US-EIN31-0888197published by the sourcedata.sec.gov/submissions/CIK0000794172.json2026-10-21

Former names

NameFromTo
MERIDIAN DIAGNOSTICS INC1995-10-112001-02-12

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0000794172.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0000794172.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000794172" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000794172/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000794172/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"794172"}

On SEC EDGAR

About this data